David Hodgson

3.8k total citations · 1 hit paper
31 papers, 468 citations indexed

About

David Hodgson is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, David Hodgson has authored 31 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Infectious Diseases. Recurrent topics in David Hodgson's work include Respiratory viral infections research (10 papers), Pneumonia and Respiratory Infections (7 papers) and Asthma and respiratory diseases (7 papers). David Hodgson is often cited by papers focused on Respiratory viral infections research (10 papers), Pneumonia and Respiratory Infections (7 papers) and Asthma and respiratory diseases (7 papers). David Hodgson collaborates with scholars based in United Kingdom, Germany and Australia. David Hodgson's co-authors include Katherine E. Atkins, Mark Jit, Jasmina Panovska‐Griffiths, Richard Pebody, Marc Baguelin, Stefan Flasche, Edwin van Leeuwen, M. P. J. Yardley, Tim Harrison and Kevin Mortimer and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and CHEST Journal.

In The Last Decade

David Hodgson

28 papers receiving 460 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination

2024 39 citations David Hodgson, N. P. Wilkins et al. The Lancet Regional Health - Europe profile →

Peers

David Hodgson

EPIDE

PRM

PHYSI

SURGE

Jia Ma China

Prasanta Raghab Mohapatra India

Thoyaja Koritala United States

Alessia Rocchi Italy

Elías Eyþórsson Iceland

Greta Di Mattia Italy

Shivank Singh China

Genevieve P. G. Fung Hong Kong

Syed Anjum Khan United States

Elettra Berti Italy

Jia Ma China

David Hodgson

76 ×0.3

EPIDE

68 ×0.4

PRM

193 ×1.9

56 ×0.9

PHYSI

62 ×1.3

SURGE

Citations per year, relative to David Hodgson David Hodgson (= 1×) peers Jia Ma

Countries citing papers authored by David Hodgson

Since Specialization

Citations

This map shows the geographic impact of David Hodgson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hodgson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hodgson more than expected).

Fields of papers citing papers by David Hodgson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hodgson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hodgson. The network helps show where David Hodgson may publish in the future.

Co-authorship network of co-authors of David Hodgson

This figure shows the co-authorship network connecting the top 25 collaborators of David Hodgson. A scholar is included among the top collaborators of David Hodgson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hodgson. David Hodgson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hodgson, David, et al.. (2025). serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data. PLoS Computational Biology. 21(9). e1013467–e1013467. 1 indexed citations

Hodgson, David, Yi Liu, Louise Carolan, et al.. (2025). Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines. Frontiers in Immunology. 16. 1487066–1487066. 1 indexed citations

Hodgson, David, Louise Carolan, Yi Liu, et al.. (2024). Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity. Vaccine. 44. 126579–126579. 4 indexed citations

Krauer, Fabienne, Marina Treskova, Mihály Koltai, et al.. (2024). Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study. BMC Medicine. 22(1). 478–478. 2 indexed citations

Hodgson, David, N. P. Wilkins, Edwin van Leeuwen, et al.. (2024). Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination. The Lancet Regional Health - Europe. 38. 100829–100829. 39 indexed citations breakdown →

Hodgson, David, et al.. (2023). A systematic review and meta-analysis of the effects of non-pharmacological interventions on quality of life in adults with multiple sclerosis. European journal of medical research. 28(1). 294–294. 8 indexed citations

Li, Xiao, David Hodgson, Alexia Kieffer, et al.. (2022). Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study. Value in Health. 26(4). 508–518. 29 indexed citations

Hodgson, David, Mihály Koltai, Fabienne Krauer, et al.. (2022). Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales. Vaccine. 40(49). 7151–7157. 21 indexed citations

Koltai, Mihály, Fabienne Krauer, David Hodgson, et al.. (2022). Determinants of RSV epidemiology following suppression through pandemic contact restrictions. Epidemics. 40. 100614–100614. 25 indexed citations

10.

Li, You, David Hodgson, Xin Wang, et al.. (2021). Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. The Lancet Infectious Diseases. 21(9). 1303–1312. 42 indexed citations

11.

Hodgson, David, Richard Pebody, Jasmina Panovska‐Griffiths, Marc Baguelin, & Katherine E. Atkins. (2020). Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis. BMC Medicine. 18(1). 348–348. 46 indexed citations

12.

Hodgson, David, Marc Baguelin, Edwin van Leeuwen, et al.. (2017). Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. The Lancet Public Health. 2(2). e74–e81. 33 indexed citations

13.

Hodgson, David, John R. Anderson, Catherine Reynolds, et al.. (2016). The Effects of Azithromycin in Treatment-Resistant Cough. CHEST Journal. 149(4). 1052–1060. 37 indexed citations

14.

Anderson, John R., Kevin Mortimer, Li Pang, et al.. (2016). Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial. PLoS ONE. 11(8). e0160257–e0160257. 30 indexed citations

15.

Forster, Sarah, Susan M. Smith, Priya Daniel, et al.. (2016). Optimising prescription and titration of oxygen for adult inpatients using novel silicone wristbands: results of a pilot project at three centres. Clinical Medicine. 16(4). 330–334. 2 indexed citations

16.

Hodgson, David, et al.. (2015). BET 2: In patients presenting with an exacerbation of COPD can a normal venous blood gas pCO₂rule out arterial hypercarbia?. Emergency Medicine Journal. 32(3). 251–253. 2 indexed citations

17.

Hodgson, David, John R. Anderson, Catherine Reynolds, et al.. (2015). A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA). Thorax. 70(6). 559–565. 13 indexed citations

18.

Hodgson, David, Gauri Saini, Charlotte E. Bolton, & Michael Steiner. (2011). Thorax in focus: chronic obstructive pulmonary disease. Thorax. 67(2). 171–176. 5 indexed citations

19.

Hodgson, David, Kevin Mortimer, & Tim Harrison. (2010). Budesonide/formoterol in the treatment of asthma. Expert Review of Respiratory Medicine. 4(5). 557–566. 8 indexed citations

20.

Hodgson, David, et al.. (1999). Paediatric epiglottitis: the influence of the Haemophilus influenzae b vaccine, a ten-year review in the Sheffield region. Clinical Otolaryngology. 24(5). 447–448. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact